BRCA HRT RCT Pilot (BRCA Mutations) - Clinical Trial

¿Cuál es el Propósito de este estudio?

We are doing this study to better understand women's preferences for and concerns about hormone replacement. We want to learn from women who have had their fallopian tubes and ovaries removed due to BRCA1 and BRCA2 mutations.

¿Cuál es la Condición que se está estudiando?

Hormone Replacement After Surgery Related to BRCA Mutations

¿Quién puede participar en el Estudio?

Women ages 19-49 who:

  • Are diagnosed with a BRCA1 or BRCA2 mutation
  • Are scheduled to have a risk reducing surgery with a gynecologic oncologist
  • Do not have any history of cancer

For more information, contact the study team at amelia.lorenzo@duke.edu.

Grupo etario
Adultos

¿Qué Implica?

If you choose to join this study, you will fill out brief surveys at several time points before and after your surgery. You will also get a random assignment (like a coin flip) to either receive standard of care counseling about hormone replacement therapy or the standard of care plus an educational video.

Detalles del Estudio

Título Completo
Patient-centered education about hormone replacement therapy after risk-reducing salpingo-oophorectomy: a pilot randomized controlled trial
Investigador Principal
Laura J. Havrilesky, MD, MHSc
Especialista en oncología ginecológica
Número de Protocolo
IRB: PRO00117007
NCT: NCT06972719
Fase
Fase N/A
ClinicalTrials.gov
Estado de inscripción
Abierto para inscripción
Apoye la investigación de Duke Health o rinda homenaje a un ser querido con un regalo conmemorativo.
Contribuya a Duke Health